Kugonza Bernard

Kampala Pharmaceutical Industries (1996) Ltd, is part of the Aga Khan Development Network (AKDN), and specifically under AKFED, which is the Aga Khan Fund for Economic Development. Under the Industrial arm of AKFED, which is IPS (Industrial Promotion services), whose headquarters are in Paris France, and a regional office in Nairobi Kenya, KPI is among the spectrum of industries and factories under this conglomerate.
As Head of Finance, my role is diverse as I not only report to AKFED, the shareholder in KPI, but also to a sitting governing board at IPS in Nairobi, Kenya. In addition to the above, I also provide strategic leadership to the management team of KPI (1996) Ltd as well as oversee and supervise all the financial and operational aspects of the company and its subsidiaries. From sales of UGX 10 billion in 2007, when I joined the company, together with the management team, we have been able to register a business growth of over 300% in a period of 10 years.
With support from the KPI management team, I have successfully supervised and implemented new areas in business including acquisition of two subsidiaries, namely BOMGI nutraceuticals ( dealing in Nutraceuticals) and KPI HC, the trade and export arm of KPI (1996) Ltd, as well as venturing into the Veterinary business.
Due to the confidence that the board has in the management, approval has been obtained to construct a brand new pharmaceutical factory, in the East African region, at a cost of over USD 20M. The combined impact of this investment will not only be creation of job opportunities but also, a reduction in the total imported pharmaceutical products within the region thereby creating a favorable Balance of Payment (BOP) position generally.